KENALOG-80 Drug Patent Profile
✉ Email this page to a colleague
When do Kenalog-80 patents expire, and what generic alternatives are available?
Kenalog-80 is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in KENALOG-80 is triamcinolone acetonide. Eighty suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kenalog-80
A generic version of KENALOG-80 was approved as triamcinolone acetonide by SUN PHARMA CANADA on October 1st, 1986.
US Patents and Regulatory Information for KENALOG-80
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | KENALOG-80 | triamcinolone acetonide | INJECTABLE;INJECTION | 014901-002 | Apr 12, 2019 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
